Cellectis to Present at Two Upcoming International Investor Conferences
Location:
Paris
Year:
2011
Communiqués de presse
Paris, September 6, 2011 – Cellectis (Alternext: ALCLS), the French Genome engineering specialist, will present at the UBS Global Life Sciences Conference in New York City on September 20, 2011, and at the MidCap Event in Paris on September 22 & 23, 2011.
Marc Le Bozec, CFO, will present the activities and the development strategy of the Cellectis group at the UBS Global Life Sciences Conference at the Grand Hyatt New York hotel on Tuesday, September 20,2011 at 11:30 am ET.
André Choulika, Chairman and CEO, and Marc Le Bozec, CFO, will present Cellectis at the MidCap Event at Palais Brongniart in Paris on September 22-23.
Document:
date:
06 September 2011